We are live on ! Find out more
State of Wisconsin Investment Board

State of Wisconsin Investment Board Portfolio holdings

AUM $43.7B
1-Year Est. Return 27.76%
This Fund
S&P 500
This Quarter Est. Return
+0.4%
1 Year Est. Return
+27.76%
3 Year Est. Return
+95.56%
5 Year Est. Return
+123.77%
10 Year Est. Return
+486.44%
AUM
$48.3B
AUM Growth
-$47.5M
Cap. Flow
+$293M
Cap. Flow %
0.61%
Top 10 Hldgs %
19.42%
Holding
2,220
New
160
Increased
1,052
Reduced
474
Closed
103

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$94.9M
2
SBUX icon
Starbucks
SBUX
+$69.4M
3
SJM icon
J.M. Smucker
SJM
+$65.7M
4
ARKK icon
ARK Innovation ETF
ARKK
+$64M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$60M

Top Sells

Rank Stock Value
1
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$177M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$112M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$103M
4
BDX icon
Becton Dickinson
BDX
+$80.7M
5
AXP icon
American Express
AXP
+$73.9M

Sector Composition

Rank Sector Weight
1 Technology 23.22%
2 Financials 13.94%
3 Healthcare 12.69%
4 Consumer Discretionary 11.51%
5 Communication Services 10.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AKBA icon
1676
Akebia Therapeutics
AKBA
$241M
$535K ﹤0.01%
185,734
– –
TSEM icon
1677
Tower Semiconductor
TSEM
$28.6B
$535K ﹤0.01%
17,726
-3,408
-16% -$98.1K
AL
1678
DELISTED
Air Lease Corp
AL
$528K ﹤0.01%
13,419
+643
+5% +$26.2K
RLMD icon
1679
Relmada Therapeutics
RLMD
$507M
$527K ﹤0.01%
20,100
– –
TKR icon
1680
Timken Company
TKR
$9.1B
$527K ﹤0.01%
8,050
+385
+5% +$28.6K
CRI icon
1681
Carter's
CRI
$1.44B
$525K ﹤0.01%
5,396
+253
+5% +$25.5K
MNDT
1682
DELISTED
Mandiant, Inc. Common Stock
MNDT
$523K ﹤0.01%
29,381
+1,392
+5% +$26.4K
TCRT icon
1683
Alaunos Therapeutics
TCRT
$4.86M
$522K ﹤0.01%
1,913
– –
KDNY
1684
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$519K ﹤0.01%
40,700
+7,776
+24% +$102K
FL
1685
DELISTED
Foot Locker
FL
$518K ﹤0.01%
11,348
+525
+5% +$29.2K
ICPT
1686
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$518K ﹤0.01%
34,900
– –
CVM icon
1687
CEL-SCI Corp
CVM
$26M
$515K ﹤0.01%
1,563
-474
-23% -$138K
CLVS
1688
DELISTED
Clovis Oncology, Inc.
CLVS
$514K ﹤0.01%
115,282
– –
EVLO
1689
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$508K ﹤0.01%
3,610
+1,278
+55% +$253K
NVMI
1690
Nova
NVMI
$13.1B
$505K ﹤0.01%
4,966
-850
-15% -$84.3K
SNRHU
1691
DELISTED
Senior Connect Acquisition Corp. I Unit
SNRHU
$504K ﹤0.01%
50,000
– –
KMPR icon
1692
Kemper
KMPR
$1.59B
$503K ﹤0.01%
7,534
+259
+4% +$17.6K
SPB icon
1693
Spectrum Brands
SPB
$2.09B
$502K ﹤0.01%
5,251
+247
+5% +$21K
NCNO icon
1694
nCino
NCNO
$2.26B
$500K ﹤0.01%
7,035
+1,422
+25% +$94.8K
UNVR
1695
DELISTED
Univar Solutions Inc.
UNVR
$500K ﹤0.01%
20,970
+996
+5% +$23.5K
ETACU
1696
DELISTED
E.Merge Technology Acquisition Corp. Unit
ETACU
$498K ﹤0.01%
50,000
– –
DNZ.U
1697
DELISTED
D and Z Media Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-third of one Warrant
DNZ.U
$497K ﹤0.01%
50,000
+23,292
+87% +$231K
ARTA
1698
DELISTED
Artisan Acquisition Corp. Class A Ordinary Shares
ARTA
$496K ﹤0.01%
+50,000
New +$487K
CYD icon
1699
China Yuchai International
CYD
$1.71B
$494K ﹤0.01%
36,384
– –
ATOS icon
1700
Atossa Therapeutics
ATOS
$25.5M
$493K ﹤0.01%
10,087
– –
66 67
68
69 70

Similar funds

Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

State of Wisconsin Investment Board's Q3 2021 Portfolio in Review

As of Q3 2021, State of Wisconsin Investment Board held 2,220 positions worth $48.3B, down 0.1% from $48.3B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

State of Wisconsin Investment Board's Q3 2021 filing shows 160 new, 1,052 increased, 474 reduced and 103 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 438,532 shares worth $32.6M. The largest sale was Royal Dutch Shell PLC ADS Class B, an estimated $177M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • State of Wisconsin Investment Board's largest Q3 2021 buy was iShares Core MSCI EAFE ETF: 438,532 shares worth $32.6M.
  • State of Wisconsin Investment Board added most to Pfizer in Q3 2021, an estimated $94.9M increase.
  • State of Wisconsin Investment Board's biggest Q3 2021 reduction was Royal Dutch Shell PLC ADS Class B, cutting an estimated $177M.
  • State of Wisconsin Investment Board fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $103M.
  • State of Wisconsin Investment Board's ten largest holdings make up 19% of its $48.3B portfolio in Q3 2021.
  • State of Wisconsin Investment Board opened 160 new positions and closed 103 in Q3 2021.
  • State of Wisconsin Investment Board's portfolio value fell 0.1% quarter-over-quarter to $48.3B.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2021, filed 12 Nov 2021.